BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 37895457)

  • 1. Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques.
    Hughes T; Harper P; Somani BK
    Life (Basel); 2023 Oct; 13(10):. PubMed ID: 37895457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Technologies for the Surgical Management of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Obstruction. A Systematic Review.
    Dey A; Mamoulakis C; Hasan N; Yuan Y; Shakil A; Omar MI
    Eur Urol Focus; 2023 Sep; ():. PubMed ID: 37741783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and interventional treatment of benign prostatic obstruction: An evidence-based comparative review.
    Malde S; Lam W; Adwin Z; Hashim H
    BJUI Compass; 2021 Jul; 2(4):238-259. PubMed ID: 35475299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally Invasive Therapies for Benign Prostatic Obstruction: A Review of Currently Available Techniques Including Prostatic Artery Embolization, Water Vapor Thermal Therapy, Prostatic Urethral Lift, Temporary Implantable Nitinol Device and Aquablation.
    Bilhim T; Betschart P; Lyatoshinsky P; Müllhaupt G; Abt D
    Cardiovasc Intervent Radiol; 2022 Apr; 45(4):415-424. PubMed ID: 35043243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Madersbacher S; Roehrborn CG; Oelke M
    BJU Int; 2020 Sep; 126(3):317-326. PubMed ID: 32599656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis.
    Franco JVA; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    BJU Int; 2022 Aug; 130(2):142-156. PubMed ID: 34820997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment.
    Lebdai S; Chevrot A; Doizi S; Pradere B; Delongchamps NB; Benchikh A; Cornu JN; Della Negra E; Fourmarier M; Misraï V; Theveniaud PE; Descazeaud A; Robert G;
    World J Urol; 2019 Feb; 37(2):299-308. PubMed ID: 29967947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.
    Tanneru K; Jazayeri SB; Alam MU; Kumar J; Bazargani S; Kuntz G; Palayapalayam Ganapathi H; Bandyk M; Marino R; Koochekpour S; Gautam S; Balaji KC; Costa J
    J Endourol; 2021 Apr; 35(4):409-416. PubMed ID: 32962442
    [No Abstract]   [Full Text] [Related]  

  • 9. Complications associated with minimally invasive surgical therapies (MIST) for surgical management of benign prostatic hyperplasia: a Manufacturer and User Facility Device Experience (MAUDE) database review.
    Porto JG; Arbelaez MCS; Blachman-Braun R; Bhatia A; Bhatia S; Satyanarayana R; Marcovich R; Shah HN
    World J Urol; 2023 Jul; 41(7):1975-1982. PubMed ID: 37222779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate.
    Prudhomme T; Marquette T; Péré M; Patard PM; Michiels C; Sallusto F; Rigaud J; Glémain P; Kamar N; Blancho G; Soulié M; Rischmann P; Karam G; Gamé X; Robert G; Branchereau J
    J Endourol; 2020 Feb; 34(2):184-191. PubMed ID: 31588793
    [No Abstract]   [Full Text] [Related]  

  • 11. Benign prostatic hyperplasia: an update on minimally invasive therapy including Aquablation.
    Das AK; Han TM; Uhr A; Roehrborn CG
    Can J Urol; 2020 Aug; 27(S3):2-10. PubMed ID: 32875996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment options for benign prostatic obstruction: beyond prostate volume.
    Deyirmendjian C; Elterman D; Chughtai B; Zorn KC; Bhojani N
    Curr Opin Urol; 2022 Jan; 32(1):102-108. PubMed ID: 34669611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; Reddy B; McCutcheon KA; Borofsky M; Narayan V; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012832. PubMed ID: 31128077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction.
    Bhat A; Blachman-Braun R; Herrmann TRW; Shah HN
    World J Urol; 2022 Apr; 40(4):889-905. PubMed ID: 34212237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures.
    Franco JVA; Tesolin P; Jung JH
    Prostate Int; 2023 Mar; 11(1):1-7. PubMed ID: 36910900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of minimally invasive surgical procedures for Male Lower Urinary Tract Symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review.
    Gemma L; Pecoraro A; Sebastianelli A; Spatafora P; Sessa F; Nicoletti R; Gravas S; Campi R; Serni S; Gacci M
    Prostate Cancer Prostatic Dis; 2024 Feb; ():. PubMed ID: 38355729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update.
    Knight L; Dale M; Cleves A; Pelekanou C; Morris R
    Appl Health Econ Health Policy; 2022 Sep; 20(5):669-680. PubMed ID: 35843995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.